http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31b45ac1d926059b9545179907316143
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sridhar |
| name | Srikala S. Sridhar Srikala S Sridhar |
| given-name | Srikala S Srikala S. |
| organization-name | Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G 2C1, Canada Princess Margaret Cancer Centre Toronto Ontario Canada Division of Medical Oncology and Hematology Princess Margaret Cancer Centre Toronto ON Canada Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. Department of Medical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada Princess Margaret Cancer Centre, Toronto, Ontario, Canada Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada Department of Medical Oncology, Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada. Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada Department of Medical Oncology and Hematology Princess Margaret Cancer Center Toronto Ontario Canada Department of Medical Oncology and Hematology Princess Margaret Cancer Center Toronto ON Canada Princess Margaret Hospital, Toronto, Ontario, Canada Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada. Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada Princess Margaret Cancer Centre University Health Network University of Toronto Toronto Ontario Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada Girish S. Kulkarni, Thomas Hermanns, Yanliang Wei, Bimal Bhindi, Raj Satkunasivam, Paul Athanasopoulos, Peter J. Bostrom, Kathy Li, Arnoud J. Templeton, Srikala S. Sridhar, Peter Chung, Robert G. Bristow, Michael Milosevic, Padraig Warde, Neil E. Fleshner, Michael A.S. Jewett, Shaheena Bashir, and Alexandre R. Zlotta, Princess Margaret Cancer Center, University Health Network, University of Toronto; Cynthia Kuk and Alexandre R. Zlotta, Mount Sinai Hospital, University of Toronto; Theodorus H. Van Der... Authors' Affiliations: 1Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada; 2Department of Urology, University of California at San Francisco, San Francisco, California; and 3Department of Surgical Oncology, Princess Margaret Hospital and 4Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada; Authors' Affiliations: 1Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada; 2Department of Urology, University of California at San Francisco, San Francisco, California; and 3Department of Surgical Oncology, Princess Margaret Hospital and 4Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2C1, Canada Professor of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 700 University Avenue, Toronto, ON M5G 1Z5, Canada Princess Margaret Cancer Centre; Toronto Ontario Canada Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada Professor, University of Toronto, Medical Oncologist, Princess Margaret Cancer Center, Chair, GU Medical Oncologists of Canada, 7-625 -700 University Avenue, Toronto, ON M5G 2M9, Canada Division of Urology, Department of Surgery (NP, AF, RG, GK), University of Toronto and University Health Network, Toronto, Ontario, Canada; Toronto Health Economics and Technology Assessment Collaborative (MDK, KEBo, KEBr), University of Toronto and University Health Network, Toronto, Ontario, Canada; Division of Internal Medicine and Geriatrics (MDK, SMHA), University of Toronto and University Health Network, Toronto, Ontario, Canada; Department of Medical Oncology (SSS), University of Toronto and University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology (PC), University of Toronto and University Health Network, Toronto, Ontario, Canada Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada Medical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Scott T. Tagawa, Weill Cornell Medical College, New York; David Shaffer, New York Oncology Hematology, Albany, NY; Manish Kohli, Mayo Clinic, Rochester, MN; Andrea Eisen, Sunnybrook Health Sciences Centre; Srikala S. Sridhar, Princess Margaret Hospital, Toronto; Christina Canil, Ottawa Hospital Cancer Centre, Ottawa, Ontario; Kim N. Chi, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Alexander Spira, Virginia Cancer... Division of Hematology and Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada. Princess Margaret Hospital Cancer Center, Toronto, Ontario, Canada Department of Medical Oncology and Hematology; Princess Margaret Cancer Center; University Health Network; Toronto Canada Princess Margaret Cancer Centre and University of Toronto; Toronto Ontario Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada Princess Margaret Hospital, University Health Network, Toronto, Canada. Authors' Affiliation: Department of Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada Division of Medical Oncology, Department of Medicine, Prince Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre Princess Margaret Hospital Toronto ON Canada Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada. Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada; Division of Medical Oncology and Hematology Department of Medicine University of Toronto Toronto Ontario Canada Princess Margaret Hospital, Toronto, ON M5G 2C1, Canada Princess Margaret Hospital and University of Toronto, Department of Medical Oncology and Hematology, Toronto, Ontario, Canada Division of Medical Oncology, Princess Margaret Cancer Center, University of Toronto, 7-625 OPG, 610 University Avenue, Toronto, ON, Canada, M5G 2M9 Division of Hematology and Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada From Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St. Bartholomew’s Hospital, London (T.P.); Sungkyunkwan University Samsung Medical Center, Seoul, South Korea (S.H.P.); Centre Jean Bernard Clinique Victor Hugo, Le Mans (E.V.), and Gustave Roussy, INSERM Unité 981, Université Paris-Saclay, Villejuif (Y.L.) — both in France; the Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni (C.C.), and Pfizer, Milan (C.F., A.P.) — both in Italy; the Department... Princess Margaret Cancer Center Toronto Ontario Canada |
Incoming Links
Showing number of triples: 1 to 202 of 202.